CARA Systems

AI-driven software that analyzes medical images to detect plaque buildup in the heart's arteries

Series C · $106M · 2024-12

AI-native radiology practice: AI embedded in physicians' diagnostic workflows speeds image interpretation while retaining physician review

Series A · 2026-09

Promaxo builds a point-of-care low-field MRI platform with AI-driven cancer risk scoring and robotic guidance for in-office prostate biopsy and treatment.

Equity + Debt · 2026-10

AI + digital pathology focused on core diagnostic needs: full-chain digital pathology department solutions incl. smart scanning, QC and multi-cancer analysis; develops the DeepPathAI pathology model.

Series C · 2026-07

AI medical imaging analysis platform

Series B · $13M · 2024-02

Developer of AI precision diagnosis and treatment platforms for cardiovascular and cerebrovascular disease and of vascular interventional surgical robots.

Strategic · 2026-07

3D deep learning analysis of lung/heart scans, providing imaging CRO services, AI biomarkers and precision endpoints for pharma trials

Series B · $31M · 2026-07

AI software development for medical imaging

Series B · $30M · 2023-07

Integrates multiple AI tools into radiology workflows to help radiologists analyze medical images more efficiently

Series A · $13M · 2024-07

Sonaro is a Montreal-based cardiovascular medtech startup founded in 2023. Its AI-powered Vaso3D software converts routine 2D carotid ultrasound into 3D vessel and plaque models for stroke-risk screening.

Point-of-care ultrasound AI software (OnX platform) for non-invasive liver disease detection and monitoring from raw acoustic signals ("virtual biopsy")

$764K

Provides a clinical AI imaging analysis platform that uses AI to read CT, X-ray and other medical images, flag abnormalities and assist with case prioritization

Series D+ · $500M · 2026-05